<DOC>
	<DOCNO>NCT01925261</DOCNO>
	<brief_summary>This one-year study design investigate safety efficacy TPX-100 , 23-amino acid chondrogenic peptide , deliver intra-articular injection , regeneration knee cartilage subject bilateral osteoarthritis knee .</brief_summary>
	<brief_title>A Study Evaluating Safety Efficacy Intra-articular Injections TPX-100 Subjects With Mild Moderate Patello-Femoral Osteoarthritis Involving Both Knees</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Age ≥ 25 ≤ 75 2 . Patellofemoral osteoarthritis knee mild moderate severity intact meniscus ligamentous stability ( cruciate collateral ligament ) Clinically , determine screen questionnaire judgment Principal Investigator ( may support image study knee ) ; confirm centrally read screen MRI knee indicate ICRS Grade 13 , ICRS Grade 4 focal defect , great 1 cm . Meniscus intact ( MRI degenerative signal include grade II acceptable ) Cruciate collateral ligament stability define clinical examination 3 . Able read , understand , sign date subject inform consent 4 . Willingness use acetaminophen primary analgesic ( painrelieving ) study medication . The maximum dose acetaminophen must exceed 4 grams/day ( 4000 mg per day ) . 5 . Willingness use hydrocodone/acetaminophen breakthrough pain injection period ( study day 30 ) . 6 . Willingness use nonsteroidal antiinflammatory drug ( NSAIDS ) aspirin , ibuprofen , naproxen first 30 day study . 7 . Female subject child bear potential sexually active ( nonabstinent ) must agree comply use 2 highly effective method birth control ( oral contraceptive , implant , injectable indwell intrauterine device , condom spermicide , sexual abstinence ) participate study . 1 . Contraindication MRI , include : metallic fragment , clip device brain , eye , spinal canal ; implant device magnetically program ; weight &gt; 300 lb . ; moderate severe claustrophobia ; previous intolerance MRI procedure 2 . ICRS grade great Grade 3 , Grade 4 focal defect great 1 cm , confirm centrallyread screen MRI 3 . MRI evidence inflammatory hypertrophic synovitis 4 . Prior surgery knee , exclude procedure debridement ( microfracture ) 5 . Joint replacement knee surgery plan next 12 month 6 . History rheumatoid arthritis , psoriatic arthritis , autoimmune infectious cause arthritis 7 . Knee effusion &gt; 2+ follow clinical scale : Zero = No wave produce downstroke Trace = Small wave medial side downstroke 1+ = Larger bulge medial side downstroke 2+ = Effusion spontaneously return medial side upstroke ( downstroke necessary ) 3+ = So much fluid possible move effusion medial aspect knee 8 . Last viscosupplementation ( e.g . Synvisc® similar hyaluronic acid product ) inject either knee &lt; 3 month screen 9 . Last intraarticular knee injection corticosteroid &lt; 2 month screen 10 . Use steroid ( except inhale corticosteroid respiratory problem ) previous month screen 11 . Known hypersensitivity TPX100 12 . Known hypersensitivity acetaminophen hydrocodone 13 . History arthroscopy either knee last 3 month screen 14 . History septic arthritis , gout pseudogout , either knee previous year screen 15 . Clinical sign acute meniscal tear ( lock , new acute mechanical symptom consistent meniscal tear ) 16 . Patellar chondrocalcinosis XRay 17 . Skin problem , rash hypersensitivity , affect either knee injection site 18 . Bleeding problem , platelet coagulation deficiency contraindicating , doctor 's opinion , intraarticular injection 19 . Active systemic infection 20 . Current treatment treatment within previous 2 year prior Screening Visit malignancy except basal cell squamous cell carcinoma skin , unless specific write permission provide Sponsor 's medical monitor 21 . Women childbearing potential pregnant , nursing , plan become pregnant , agree remain acceptable method birth control throughout entire study period 22 . Participation clinical osteoarthritis drug study within one year prior screen 23 . Currently take Paclitaxel ( mitotic inhibitor ) , Natalizumab ( antiintegrin monoclonal antibody ) . 24 . History significant liver disease consumption 3 alcoholic drink day . ( Definition one alcoholic drink : 12ounces beer , 8ounces malt liquor , 5ounces wine , 1.5ounces `` shot '' 80proof distil spirit liquor gin , rum , vodka , whiskey ) .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>knee osteoarthritis</keyword>
	<keyword>bilateral</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>